A normal genetic variation modulates synaptic MMP‐9 protein levels and the severity of schizophrenia symptoms

Matrix metalloproteinase 9 (MMP‐9) has recently emerged as a molecule that contributes to pathological synaptic plasticity in schizophrenia, but explanation of the underlying mechanisms has been missing. In the present study, we performed a phenotype‐based genetic association study (PGAS) in > 1,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EMBO Mol Med
Main Authors: Lepeta, Katarzyna, Purzycka, Katarzyna J, Pachulska‐Wieczorek, Katarzyna, Mitjans, Marina, Begemann, Martin, Vafadari, Behnam, Bijata, Krystian, Adamiak, Ryszard W, Ehrenreich, Hannelore, Dziembowska, Magdalena, Kaczmarek, Leszek
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5538295/
https://ncbi.nlm.nih.gov/pubmed/28623238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201707723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados